Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Phosphoproteomic dysregulation in Huntington’s disease mice is rescued by environmental enrichment
Isaline Mees, Shanshan Li, Harvey Tran, et al.
Brain Communications (2022) Vol. 4, Iss. 6
Open Access | Times Cited: 13

Showing 13 citing articles:

PYK2 in the dorsal striatum of Huntington's disease R6/2 mouse model
Omar Al–Massadi, Mélody Labarchède, Benoit de Pins, et al.
Neurobiology of Disease (2025), pp. 106840-106840
Open Access
Targeting the ribosome to treat multiple myeloma
Kylee Maclachlan, Kezia Gitareja, Jian Kang, et al.
Deleted Journal (2024) Vol. 32, Iss. 1, pp. 200771-200771
Open Access | Times Cited: 2
Omics and Network-based Approaches in Understanding HD Pathogenesis
Christiana Christodoulou, Eleni Zamba Papanicolaou
IntechOpen eBooks (2024)
Open Access | Times Cited: 2
Circadian Interventions in Preclinical Models of Huntington’s Disease: A Narrative Review
Derek Dell’Angelica, Karan Singh, Christopher S. Colwell, et al.
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1777-1777
Open Access | Times Cited: 2
The relationship between disease-specific psychosocial stressors and depressive symptoms in Huntington’s disease
Hiba Bilal, Ian H. Harding, Julie C. Stout
Journal of Neurology (2023) Vol. 271, Iss. 1, pp. 289-299
Open Access | Times Cited: 6
Multiple Sgip1 splice variants inhibit cannabinoid receptor 1 internalization
Oleh Durydivka, Matej Gazdarica, Kateřina Večerková, et al.
Gene (2023) Vol. 892, pp. 147851-147851
Open Access | Times Cited: 5
MSK1 is required for the beneficial synaptic and cognitive effects of enriched experience across the lifespan
Lorenzo Morè, Lucia Privitera, Daniel D. Cooper, et al.
Aging (2023) Vol. 15, Iss. 13, pp. 6031-6072
Open Access | Times Cited: 3
Untargeted Proteomic Profiling in Huntington's Disease: Unraveling Molecular Insights and Therapeutic Possibilities
Christiana C. Christodoulou, Christiana A. Demetriou, Eleni Zamba Papanicolaou
(2024)
Closed Access
Phosphoproteomics implicates glutamatergic and dopaminergic signalling in the antidepressant-like properties of the iron chelator deferiprone
Volkan Uzungil, Sandra Luza, Carlos Opazo, et al.
Neuropharmacology (2024) Vol. 246, pp. 109837-109837
Open Access
Unbiased genome-wide approaches to identify vulnerability factors in Huntington's disease
Suphinya Sathitloetsakun, Myriam Heiman
Elsevier eBooks (2024), pp. 397-410
Closed Access
Levels of Synaptic Proteins in Brain and Neurofilament Light Chain in Cerebrospinal Fluid and Plasma of OVT73 Huntington’s Disease Sheep Support a Prodromal Disease State
Ellen Sapp, Adel Boudi, Suzanne J. Reid, et al.
Journal of Huntington s Disease (2023) Vol. 12, Iss. 3, pp. 201-213
Open Access | Times Cited: 1
Phosphoproteomics implicates glutamatergic and dopaminergic signalling in the antidepressant-like properties of the iron chelator deferiprone
Volkan Uzungil, Sandra Luza, Carlos Opazo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Targeting the ribosome to treat multiple myeloma
Kylee Maclachlan, Kezia Gitareja, Jian Kang, et al.
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top